UNSPSC 51352400: Combination contraceptives and estrogens

This classification denotes combination drugs and preparations that a) prevent or reduce probability of fusion of a spermatozoon with an ovum thus resulting in the formation of a zygote (or fertilization), that process called conception, hence the term contraceptives; and/or b) interact with estrogen receptors (or Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription) in target tissues and which thereby stimulate human female reproductive organs.

Typical combination contraceptive and estrogen constituents are chlordiazepoxide, desogestrel, dienogest, drospirenone, estradiol, estrogens, ethinyl estradiol, ethynodiol, and mestranol.

UNSPSC 51352400 Combination contraceptives and estrogens is a Class code that covers oral contraceptive formulations and hormone-replacement products state and local health departments, school districts, and public health clinics procure for family planning programs, reproductive health services, and public health initiatives. The scope encompasses branded and generic oral contraceptive tablets, combination estrogen-progestin formulations, and related pharmaceutical products that public health agencies dispense through clinics, community health centers, and school-based health services.

The source provided contains no records of recent state and local contract opportunities tagged to this code, and therefore does not support characterization of issuing-body mix, geographic concentration, or representative recent solicitations.